Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Ceftriaxone for Injection, USP is supplied as a sterile crystalline powder in glass vials. The following packages are available:
Bulk pharmacy containers, containing 10 gm equivalent of ceftriaxone. Box of 1 (NDC 60505-0679-5). NOT FOR DIRECT ADMINISTRATION.
OTHER SIZE PACKAGE AVAILABLE
Vials containing 250 mg equivalent of ceftriaxone. Box of 1 (NDC 60505-0750-0) and
box of 10 (NDC 60505-0750-4).
Vials containing 500 mg equivalent of ceftriaxone. Box of 1 (NDC 60505-0751-0) and box of 10 (NDC 60505-0751-4).
Vials containing 1 gm equivalent of ceftriaxone. Box of 1 (NDC 60505-0752-0) and box of 10 (NDC 60505-0752-4).
Vials containing 2 gm equivalent of ceftriaxone. Box of 1 (NDC 60505-0753-0) and box of 10 (NDC 60505-0753-4).
Piggyback bottles containing 1 gm equivalent of ceftriaxone. Box of 1(NDC 60505-6087-1).
Piggyback bottles containing 2 gm equivalent of ceftriaxone. Box of 1(NDC 60505-6088-1).
NOTE: Ceftriaxone for Injection,USP sterile powder should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light.
Flagyl® is a registered trademark of G.D. Searle LLC.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/050796lbl.pdf